NMRF Applies for a Utility Patent
In the cutting edge of medical and scientific research, a small, non-profit organization being awarded a patent feels a lot like the story of David versus Goliath. US-based universities doing research in pharmaceuticals, biotechnology and medical technology lead the field of patent awards. In 2017, the University of California was granted 524 utility patents, which is more than 200 patents ahead of the #2 recipient, Massachusetts Institute of Technology.
Under-funded by billions of dollars and outnumbered by hundreds of researchers, the Napa Medical Research Foundation seems an unlikely recipient of a patent award. But that is exactly what Head Research Consultant, Ryan Dregalla PhD is trying to achieve – the holy grail of the scientific research community, a utility patent.
Working with Marko Bodor, MD and Research Assistant, Yvette Uribe, BS, the NMRF developed a new process that is both “novel and undescribed”, according to Williams Intellectual Property. The “art,” or invention, that will be protected by the patent aims to treat platelets and optimize the growth factor yields in a bioactive state with unprecedented efficiency. With the potential to impact the fields of orthopedic and spinal medicine, as well as a number of surgical fields, this represents a major breakthrough.
Of paramount importance to the patent award process are the extensive sets of statistical data being produced by the NMRF research team. Careful mining of the vast amounts of information gathered through numerous clinical and laboratory studies has yielded critical data, which will effectively prove the newly developed process is both unique and functional ways, and will greatly increase the chances for success with the US Patent and Trademark Office.
The multi-phase process is arduous and time-consuming. However, the potential return on investment of innovation, money and hard work will likely provide important long-term benefits for the Napa Medical Research Foundation. With an aim to support the mission of sharing research findings with the broad medical community, the patent process itself may not be profitable. However, the potential for device-specific applications may include licensure, which would provide revenue in the future, as well as recognize NMRF as a leading-edge research organization.
Currently funded entirely through charitable contributions, this research is done for the benefit of our local community. The discoveries made by the NMRF researchers lead to improved medical outcomes for residents of the Napa Valley and across the Greater Bay Area.
Reduce Pain. Increase Mobility & Function. Improve Quality of Life.
All the research conducted through the Napa Medical Research Foundation, a 501(c)(3) nonprofit organization, is fully funded through generous donations received from individuals and family foundations.